Blood test breakthrough could spot hidden Hormone-Secreting tumors
NCT ID NCT07352527
First seen Jan 20, 2026 · Last updated Jun 23, 2026 · Updated 26 times
Summary
This study aims to create a new diagnostic score to help doctors identify adrenal adenomas that produce moderate amounts of cortisol, a condition called MACS. Researchers will measure 19 steroid hormones in the blood and combine them with basic health info like BMI, blood sugar, and blood pressure. The goal is to improve diagnosis in 291 patients at Bordeaux University Hospital, potentially offering a simpler and more accurate way to detect these tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCRINE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital du Haut-Lévêque
RECRUITINGPessac, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could provide a more accurate, non-invasive diagnostic tool for identifying adrenal adenomas with moderate cortisol secretion, reducing the need for complex testing.
What could go wrong
This is an early-stage study focused on developing a predictive model, not testing a treatment. The score may not perform well in broader populations or different clinical settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.